Stockscreener 앱 받기
33.86
0.59%
0.22
시간 외 거래:
34.12
0.26
+0.77%
전일 마감가:
$33.64
열려 있는:
$33.76
하루 거래량:
2.78M
Relative Volume:
0.73
시가총액:
$14.73B
수익:
$2.27B
순이익/손실:
$1.15B
주가수익비율:
13.28
EPS:
2.55
순현금흐름:
$2.80B
1주 성능:
+0.12%
1개월 성능:
+8.01%
6개월 성능:
+17.17%
1년 성능:
+13.06%
1일 변동 폭
$33.69
$34.10
1주일 범위
$32.92
$34.12
52주 변동 폭
$24.05
$34.20
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
33.86 | 14.73B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Marathon Asset Management Ltd Sells 46,981 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
53,542 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by SBI Securities Co. Ltd. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Los Angeles Capital Management LLC Sells 346,803 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $3.23 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Holdings Boosted by Illinois Municipal Retirement Fund - MarketBeat
New York State Common Retirement Fund Has $6.81 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month HighHere's What Happened - MarketBeat
Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference - The Manila Times
What Will Royalty Pharma Reveal at TD Cowen's Healthcare Conference Next Week? - StockTitan
Royalty Pharma plcOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire
8,998 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by Vontobel Holding Ltd. - MarketBeat
ING Groep NV Invests $2.92 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Handelsbanken Fonder AB Has $11.74 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at $33.71 amid growth - Investing.com Australia
Peering Into Royalty Pharma's Recent Short Interest - Benzinga
Bryn Mawr Capital Management LLC Purchases 47,964 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's Why - MarketBeat
Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025 - Insider Monkey
10 Best Performing Pharma Stocks So Far in 2025 - Insider Monkey
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Baillie Gifford & Co. Sells 1,987,975 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Van ECK Associates Corp Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Ex-Dividend Reminder: Royalty Pharma, Piedmont Office Realty Trust and Western Asset Diversified Income - Nasdaq
2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street - The Globe and Mail
(RPRX) Trading Signals - Stock Traders Daily
Royalty Pharma (RPRX) to Release Quarterly Earnings on Thursday - MarketBeat
Sumitomo Mitsui Trust Group Inc. Reduces Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
abrdn plc Sells 14,685 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat
Royalty Pharma’s Internalization Strategy: Navigating Risks and Uncertainties Ahead of 2025 Transition - MSN
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Royalty Pharma's Strong Portfolio Growth and Manager Acquisition Boost Long-Term Outlook - Morningstar
Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts - MSN
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
7.66%
자본화:
|
볼륨(24시간):